Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Monthly Archives: May 2015

Treating Oral Cancer – Catch them young!

Duncan Herald logoWorldwide, it is estimated that about a billion humans consume tobacco products. Considering the same, the Indian situation is alarming. Thirty-five crore Indians use some form of tobacco mostly in the form of gutka, khaini, quid etc. The habit of chewing tobacco is rampant across all social classes and as a result, India has a dubious distinction of being the world capital of tobacco-related oral as well as head and neck cancer. About 1 million Indians die due to tobacco-related illness and one death is reported every six hours due to oral cancer. [Read more…]


CCEDV36N5_Cover_5th.inddVolume 36, Issue 5
Published by AEGIS Communications

Evaluation of Salivary Transcriptome Markers for the Early Detection of Oral Squamous Cell Cancer in a Prospective Blinded Trial

Jack L. Martin, MD; Neil Gottehrer, DDS; Harvey Zalesin, DDS; Paul T. Hoff, MD; Michael Shaw, PhD; James H.W. Clarkson, MD; Pam Haan, BSN; Mark Vartanian; Terry McLeod, BSN; and Stephen M. Swanick